![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Georgetown University and Samaritan Sign Exclusive Licensing Agreement for Novel Treatment of Cushing's Syndrome
08 août 2007 09h52 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Aug. 8, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV), a developer of innovative drugs, announced today that it has entered into an exclusive licensing agreement with...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan's Chief Drug Development Officer to Present Lead Alzheimer's Drug At 12th IBC World Congress
02 août 2007 10h05 HE
|
Samaritan Pharmaceuticals, Inc.
Focus Area: New and Emerging Therapeutic Targets for CNS
Topic: SP-233: A New and Novel Therapy With Protective Properties Against
the Neurotoxic Effects of Beta-Amyloid Peptide
LAS VEGAS,...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Exclusively Licenses Innovative Blood Diagnostic to Uncover Whether Breast Tumor is Cancer
30 juil. 2007 10h22 HE
|
Samaritan Pharmaceuticals, Inc.
Blood Test Can Detect One Single Aggressive Cancer Cell Out of
Millions of Normal Blood Cells
Diagnostic Technology Thought to Detect Prostrate and Colon
...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Therapeutics Signs Research Collaboration and Licensing Agreement With The Research Institute of McGill University Health Centre
25 juil. 2007 10h01 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, July 25, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, and Samaritan Therapeutics, Canada, is pleased to announce it has signed a...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Licenses Exclusive Rights to Infectious Disease Compounds From Georgetown University
24 juil. 2007 09h49 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, July 24, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV), a developer of innovative drugs, announced today that it has entered into an exclusive license agreement with...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Announces Positive Preliminary Results in a Phase IIb Study For Its Novel Oral HIV Entry Inhibitor
20 juil. 2007 07h00 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, July 20, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce its novel oral HIV entry inhibitor SP-01A, being...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan's Alzheimer's Drug Caprospinol Suggests Brain May be Able to Heal From Alzheimer's Disease
10 juil. 2007 09h35 HE
|
Samaritan Pharmaceuticals, Inc.
Animal Study Confirms Caprospinol's (SP-233) Ability to Clear Brain
Plaque and Empower Rat Brain Cells to Recover Memory Function
In Vivo 'Proof of Concept' Study Proposes Direct Correlation...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Reorganizes Its Stock Structure
28 juin 2007 15h44 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, June 28, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative life-saving drugs, announced today its Board of Directors has unanimously decided to...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Nationally Recognized M.D. Joins Samaritan Pharmaceuticals' Board of Directors
12 juin 2007 10h58 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, June 12, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative life saving drugs, announces Doug Bessert has decided for personal reasons to step...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan in Collaboration With UCSD Awarded NIH Grant for the Continued Development of Samaritan's Compounds to Suppress HIV Viral Replication and Prevent Neuronal Damage
07 juin 2007 09h40 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, June 7, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce the National Institutes of Health (NIH) has awarded a...